American Portfolios Advisors Supernus Pharmaceuticals, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 2,044 shares of SUPN stock, worth $91,980. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,044Holding current value
$91,980% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding SUPN
# of Institutions
330Shares Held
60.2MCall Options Held
234KPut Options Held
0-
Black Rock Inc. New York, NY10.4MShares$468 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$272 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3MShares$135 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY2.84MShares$128 Million2.08% of portfolio
-
Macquarie Group LTD Australia, C32.53MShares$114 Million0.14% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $2.41B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...